Delivery of Protein Kinase A by CRISPRMAX and Its Effects on Breast Cancer Stem-Like Properties

Protein kinase A (PKA) activation has recently been reported to inhibit epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC) ability, which is considered to be responsible for chemoresistance and tumor recurrence in patients. While current studies mainly focus on gene manipulation of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jun-Nian, Rautio, Tzu-Chen, Liu, Chang, Xu, Xiao-Yu, Wang, Dong-Qing, Guo, Yong, Eriksson, John, Zhang, Hongbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824330/
https://www.ncbi.nlm.nih.gov/pubmed/33374889
http://dx.doi.org/10.3390/pharmaceutics13010011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824330/
https://www.ncbi.nlm.nih.gov/pubmed/33374889
http://dx.doi.org/10.3390/pharmaceutics13010011

Ejemplares similares